Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Discover what are the best high return investments available today. Equip yourself with knowledge to enhance your investment strategy.
25,106 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
As markets swing in early 2026, many investors pay active fees for funds that closely track benchmarks. Here’s a fast...
Industrial stocks can offer big turns with the right cycle. This guide shows how to analyze backlog, margins, and ris...
In February, Occidental Petroleum’s stock surged nearly 17%, powered by higher oil prices and strong earnings signals...
A triple-leveraged note tied to a tech stock basket plunged 18% in a single session, erasing much of a year’s gains a...
The past year reshaped The Trade Desk in ways that matter to investors. This article breaks down what changed, why it...
A historically cheap, safe stock is gaining attention as investors seek stability in an expensive market. NextEra Ene...
Small modular reactors could redefine electricity costs and energy security. This guide breaks down the investment th...
Marvell Technology has staged a decisive run in 2026, outpacing Broadcom in the AI accelerator stock race. As data-ce...
Oil breaks through $119 as geopolitical risk spikes. This article explains why this nuclear energy stock may stand ou...
As LNG exports push near capacity and data-center electricity demand climbs, three U.S. pipeline stocks paying wait o...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...